BIOASTER is pleased to announce that the B2B2B AMR Dx consortium has officially been recommended for funding
(B2B2B AMR Dx: Bench, Bedside, Business, and Beyond: innovative solutions for AMR diagnostics)
The aim of this JPIAMR transnational network call (JPIAMR 15th call; Diagnostics and Surveillance Networks) is to assemble networks of leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems. This network, that includes 69 partners from 22 countries, will connect experts from research performing organisations and/or establish clusters with different relevant stakeholders and end users in the AMR community.
More information at: Bench, Bedside, Business, and Beyond: innovative solutions for AMR diagnostics (B2B2B AMRDx) – JPIAMR